The role of chromatin reorganization in the process of cellular senescence

Current Drug Targets

Volumn 13, Issue 13, 2012, Pages 1593-1602

  Tominaga, Kaoru ^a   Pereira Smith, Olivia M ^b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b University of Texas Health Science Center   (United States)

Author keywords

Cell cycle; Cell proliferation; Chromatin; DNA damage response; Histone modification; Immortalization; P16 CKI; P21 CKI

Indexed keywords

BMI1 PROTEIN; CYCLIN D; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN E; POLYCOMB GROUP PROTEIN; PROTEIN CBX7; PROTEIN CBX8; PROTEIN P16; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; CANCER INHIBITION; CELL AGING; CELL CYCLE ARREST; CELL CYCLE REGULATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN STRUCTURE; DNA DAMAGE; DNA METHYLATION; DNA REPAIR; ENZYME ACTIVITY; GENE EXPRESSION; GENE LOCUS; HETEROCHROMATIN; HUMAN; KNOCKOUT GENE; NONHUMAN; ONCOGENE; OXIDATIVE STRESS; REGULATORY MECHANISM; TISSUE REPAIR; WOUND HEALING;

ANIMALS; CELL AGING; CELL CYCLE PROTEINS; CHROMATIN; HUMANS;

EID: 84870228727     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/138945012803529983     Document Type: Article

References (146)

1. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25: 585-621.
2. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965; 37: 614-636.
3. Dell'Orco RT, Mertens JG, Kruse PF, Jr. Doubling potential, calendar time, and senescence of human diploid cells in culture. Exp Cell Res 1973; 77(1): 356-360.
4. Roberts TW, Smith JR. The proliferative potential of chick embryo fibroblasts: population doublings vs. time in culture. Cell Biol Int Rep 1980; 4(12): 1057-1063.
5. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345(6274): 458-460.
6. Allsopp RC, Chang E, Kashefi-Aazam M, et al. Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res 1995; 220(1): 194-200.
7. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88(5): 593-602.
8. Chen QM, Bartholomew JC, Campisi J, Acosta M, Reagan JD, Ames BN. Molecular analysis of H2O2-induced senescent-like growth arrest in normal human fibroblasts: p53 and Rb control G1 arrest but not cell replication. Biochem J 1998; 332 (Pt 1): 43-50.
9. Chen QM. Replicative senescence and oxidant-induced premature senescence. Beyond the control of cell cycle checkpoints. Ann N Y Acad Sci 2000; 908: 111-125.
10. Toussaint O, Medrano EE, von Zglinicki T. Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes. Exp Gerontol 2000; 35(8): 927-945.
11. Ramirez RD, Morales CP, Herbert BS, et al. Putative telomereindependent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev 2001; 15(4): 398-403.
12. Wright WE, Shay JW. Historical claims and current interpretations of replicative aging. Nat Biotechnol 2002; 20(7): 682-688.
13. Campisi J, D'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8(9): 729-740.
14. Smith JR, Pereira-Smith OM. Replicative senescence: implications for in vivo aging and tumor suppression. Science 1996; 273: 63-67.
15. Pascal T, Debacq-Chainiaux F, Chretien A, et al. Comparison of replicative senescence and stress-induced premature senescence combining differential display and low-density DNA arrays. FEBS Lett 2005; 579(17): 3651-3659.
16. d'Adda di Fagagna F, Teo SH, Jackson SP. Functional links between telomeres and proteins of the DNA-damage response. Genes Dev 2004; 18(15): 1781-1799.
17. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003; 426(6963): 194-198.
18. Denchi EL, de Lange T. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature 2007; 448(7157): 1068-1071.
19. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279(5349): 349-352.
20. Wei S, Sedivy JM. Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts. Cancer Res 1999; 59(7): 1539-1543.
21. Kaul Z, Cesare AJ, Huschtscha LI, Neumann AA, Reddel RR. Five dysfunctional telomeres predict onset of senescence in human cells. EMBO Rep 2012; 13(1): 52-59.
22. Mukherjee S, Firpo EJ, Wang Y, Roberts JM. Separation of telomerase functions by reverse genetics. Proc Natl Acad Sci USA 2011; 108(50): E1363-E1371.
23. Campisi J, Andersen JK, Kapahi P, Melov S. Cellular senescence: a link between cancer and age-related degenerative disease? Semin Cancer Biol 2011; 21(6): 354-359.
24. Herbig U, Ferreira M, Condel L, Carey D, Sedivy JM. Cellular senescence in aging primates. Science 2006; 311(5765): 1257.
25. Jeyapalan JC, Ferreira M, Sedivy JM, Herbig U. Accumulation of senescent cells in mitotic tissue of aging primates. Mech Ageing Dev 2007; 128(1): 36-44.
26. Seshadri T, Campisi J. Repression of c-fos transcription and an altered genetic program in senescent human fibroblasts. Science 1990; 247(4939): 205-209.
27. Stein GH, Drullinger LF, Robetorye RS, Pereira-Smith OM, Smith JR. Senescent cells fail to express cdc2, cycA, and cycB in response to mitogen stimulation. Proc Natl Acad Sci USA 1991; 88(24): 11012-11016.
28. Stein GH, Beeson M, Gordon L. Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. Science 1990; 249(4969): 666-669.
29. Gorman SD, Cristofalo VJ. Reinitiation of cellular DNA synthesis in BrdU-selected nondividing senescent WI-38 cells by simian virus 40 infection. J Cell Physiol 1985; 125(1): 122-126.
30. Hara E, Tsurui H, Shinozaki A, Nakada S, Oda K. Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1. Biochem Biophys Res Commun 1991; 179(1): 528-534.
31. Shay JW, Pereira-Smith OM, Wright WE. A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res 1991; 196(1): 33-39.
32. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994; 211: 90-98.
33. Brown JP, Wei W, Sedivy JM. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 1997; 277: 831-834.
34. el-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75(4): 817-825.
35. Gu Y, Turck CW, Morgan DO. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 1993; 366(6456): 707-710.
36. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclindependent kinases. Cell 1993; 75(4): 805-816.
37. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993; 366(6456): 701-704.
38. Hara E, Smith R, Parry D, Tahara H, Stone S, Peters G. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 1996; 16: 859-867.
39. Stein GH, Drullinger LF, Soulard A, Dulic V. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol 1999; 19(3): 2109-2117.
40. Oshima J, Campisi J, Tannock TC, Martin GM. Regulation of c-fos expression in senescing Werner syndrome fibroblasts differs from that observed in senescing fibroblasts from normal donors. J Cell Physiol 1995; 162(2): 277-283.
41. Bandyopadhyay D, Timchenko N, Suwa T, Hornsby PJ, Campisi J, Medrano EE. The human melanocyte: a model system to study the complexity of cellular aging and transformation in non-fibroblastic cells. Exp Gerontol 2001; 36(8): 1265-1275.
42. Borrelli E, Nestler EJ, Allis CD, Sassone-Corsi P. Decoding the epigenetic language of neuronal plasticity. Neuron. 2008; 60(6): 961-974.
43. Li X, Zhao X. Epigenetic regulation of mammalian stem cells. Stem Cells Dev 2008; 17(6): 1043-1052.
44. Mehler MF. Epigenetics and the nervous system. Ann Neurol 2008; 64(6): 602-617.
45. Wen S, Li H, Liu J. Epigenetic background of neuronal fate determination. Prog Neurobiol 2009; 87(2): 98-117.
46. Lusser A, Kadonaga JT. Chromatin remodeling by ATP-dependent molecular machines. Bioessays 2003; 25(12): 1192-1200.
47. Clapier CR, Cairns BR. The biology of chromatin remodeling complexes. Annu Rev Biochem 2009; 78: 273-304.
48. Talbert PB, Henikoff S. Histone variants--ancient wrap artists of the epigenome. Nat Rev Mol Cell Biol 2010; 11(4): 264-275.
49. Carrozza MJ, Utley RT, Workman JL, Cote J. The diverse functions of histone acetyltransferase complexes. Trends Genet 2003; 19(6): 321-329.
50. Mehler MF. Epigenetic principles and mechanisms underlying nervous system functions in health and disease. Prog Neurobiol 2008; 86(4): 305-341.
51. Adams PD. Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. Gene 2007; 397(1-2): 84-93.
52. Funayama R, Ishikawa F. Cellular senescence and chromatin structure. Chromosoma 2007; 116(5): 431-440.
53. Sedivy JM, Banumathy G, Adams PD. Aging by epigenetics-a consequence of chromatin damage? Exp Cell Res 2008; 314(9): 1909-1917.
54. Narita M, Nunez S, Heard E, et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003; 113(6): 703-716.
55. Zhang R, Liu ST, Chen W, et al. HP1 proteins are essential for a dynamic nuclear response that rescues the function of perturbed heterochromatin in primary human cells. Mol Cell Biol 2007; 27(3): 949-962.
56. Zhang R, Chen W, Adams PD. Molecular dissection of formation of senescence-associated heterochromatin foci. Mol Cell Biol 2007; 27(6): 2343-2358.
57. Zhang R, Poustovoitov MV, Ye X, et al. Formation of MacroH2Acontaining senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev Cell 2005; 8(1): 19-30.
58. Narita M, Krizhanovsky V, Nunez S, et al. A novel role for highmobility group a proteins in cellular senescence and heterochromatin formation. Cell 2006; 126(3): 503-514.
59. Di Micco R, Sulli G, Dobreva M, et al. Interplay between oncogene- induced DNA damage response and heterochromatin in senescence and cancer. Nat Cell Biol 2011; 13(3): 292-302.
60. De Cecco M, Jeyapalan J, Zhao X, Tamamori-Adachi M, Sedivy JM. Nuclear protein accumulation in cellular senescence and organismal aging revealed with a novel single-cell resolution fluorescence microscopy assay. Aging (Albany NY) 2011; 3(10): 955-967.
61. Kosar M, Bartkova J, Hubackova S, Hodny Z, Lukas J, Bartek J. Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner and follow expression of p16(ink4a). Cell Cycle 2011; 10(3): 457-468.
62. Kreiling JA, Tamamori-Adachi M, Sexton AN, et al. Ageassociated increase in heterochromatic marks in murine and primate tissues. Aging Cell 2011; 10(2): 292-304.
63. Kennedy AL, McBryan T, Enders GH, Johnson FB, Zhang R, Adams PD. Senescent mouse cells fail to overtly regulate the HIRA histone chaperone and do not form robust Senescence Associated Heterochromatin Foci. Cell Div 2010; 5: 16.
64. Bandyopadhyay D, Okan NA, Bales E, Nascimento L, Cole PA, Medrano EE. Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes. Cancer Res 2002; 62(21): 6231-6239.
65. Bandyopadhyay D, Curry JL, Lin Q, et al. Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi. Aging Cell 2007; 6(4): 577-591.
66. Casillas MA, Jr., Lopatina N, Andrews LG, Tollefsbol TO. Transcriptional control of the DNA methyltransferases is altered in aging and neoplastically-transformed human fibroblasts. Mol Cell Biochem 2003; 252(1/2): 33-43.
67. Wilson VL, Jones PA. DNA methylation decreases in aging but not in immortal cells. Science 1983; 220(4601): 1055-1057.
68. Singhal RP, Mays-Hoopes LL, Eichhorn GL. DNA methylation in aging of mice. Mech Ageing Dev 1987; 41(3): 199-210.
69. Zheng QH, Ma LW, Zhu WG, Zhang ZY, Tong TJ. P21Waf1/Cip1 plays a critical role in modulating senescence through changes of DNA methylation. J Cell Biochem 2006; 98(5): 1230-1248.
70. Jacobs JJ, de Lange T. Significant role for p16INK4a in p53- independent telomere-directed senescence. Curr Biol 2004; 14(24): 2302-2308.
71. Jacobs JJ, de Lange T. P16INK4a as a second effector of the telomere damage pathway. Cell Cycle 2005; 4(10): 1364-1368.
72. Robles SJ, Adami GR. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene 1998; 16(9): 1113-1123.
73. Shapiro GI, Edwards CD, Ewen ME, Rollins BJ. P16INK4A participates in a G1 arrest checkpoint in response to DNA damage. Mol Cell Biol 1998; 18(1): 378-387.
74. Schmitt CA, Fridman JS, Yang M, et al. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 2002; 109(3): 335-346.
75. Yamakoshi K, Takahashi A, Hirota F, et al. Real-time in vivo imaging of p16Ink4a reveals cross talk with p53. J Cell Biol 2009; 186(3): 393-407.
76. Gil J, Peters G. Regulation of the INK4b-ARF-INK2a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol 2006; 7: 667-677.
77. Miki J, Fujimura Y, Koseki H, Kamijo T. Polycomb complexes regulate cellular senescence by repression of ARF in cooperation with E2F3. Genes Cells 2007; 12(12): 1371-1382.
78. Agger K, Cloos PA, Rudkjaer L, et al. The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence. Genes Dev 2009; 23(10): 1171-1176.
79. Agherbi H, Gaussmann-Wenger A, Verthuy C, Chasson L, Serrano M, Djabali M. Polycomb mediated epigenetic silencing and replication timing at the INK4a/ARF locus during senescence. PLoS One 2009; 4(5): e5622.
80. Barradas M, Anderton E, Acosta JC, et al. Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS. Genes Dev 2009; 23: 1177-1182.
81. Maertens GN, El Messaoudi-Aubert S, Racek T, et al. Several distinct polycomb complexes regulate and co-localize on the INK4a tumor suppressor locus. PLoS One 2009; 4(7): e6380.
82. Sparmann A, van Lohuizen M. Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 2006; 6(11): 846-856.
83. Schwartz YB, Pirrotta V. Polycomb silencing mechanisms and the management of genomic programmes. Nat Rev Genet 2007; 8(1): 9-22.
84. Whitcomb SJ, Basu A, Allis CD, Bernstein E. Polycomb Group proteins: an evolutionary perspective. Trends Genet 2007; 23(10): 494-502.
85. Morey L, Helin K. Polycomb group protein-mediated repression of transcription. Trends Biochem Sci 2010; 35(6): 323-332.
86. Bracken AP, Kleine-Kohlbrecher D, Dietrich N, et al. The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev 2007; 21(5): 525-530.
87. Jacobs JJL, Kieboom K, Marino S, DePinho RA, van Lohuizen M. The oncogene and polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 1999; 397: 164-168.
88. Itahana K, Zou Y, Itahana Y, et al. Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol Cell Biol 2003; 23(1): 389-401.
89. Gil J, Bernard D, Martinez D, Beach D. Polycomb CBX7 has a unifying role in cellular lifespan. Nat Cell Biol 2004; 6(1): 67-72.
90. Yap KL, Li S, Munoz-Cabello AM, et al. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell 2010; 38(5): 662-674.
91. Forzati F, Federico A, Pallante P, et al. CBX7 is a tumor suppressor in mice and humans. J Clin Invest 2012; 122(2): 612-623.
92. Dietrich N, Bracken AP, Trinh E, et al. Bypass of senescence by the polycomb group protein CBX8 through direct binding to the INK4A-ARF locus. EMBO J 2007; 26(6): 1637-1648.
93. Kotake Y, Cao R, Viatour P, Sage J, Zhang Y, Xiong Y. PRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene. Genes Dev 2007; 21(1): 49-54.
94. Pereira-Smith OM, Smith JR. Genetic analysis of indefinite division in human cells: identification of four complementation groups. Proc Natl Acad Sci USA 1988; 85: 6042-6046.
95. Bertram MJ, Berube NG, Hang-Swanson X, et al. Identification of a gene that reverses the immortal phenotype of a subset of cells and is a member of a novel family of transcription factor-like genes. Mol Cell Biol 1999; 19: 1479-1485.
96. Tominaga K, Olgun A, Smith JR, Pereira-Smith OM. Genetics of cellular senescence. Mech Ageing Dev 2002; 123: 927-936.
97. Pena AN, Pereira-Smith OM. The Role of the MORF/MRG family of genes in cell growth, differentiation, DNA repair, and thereby aging. Ann N Y Acad Sci 2007; 1100: 299-305.
98. Bertram MJ, Pereira-Smith OM. Conservation of the MORF4 related gene family: identification of a new chromo domain subfamily and novel protein motif. Gene 2001; 266: 111-121.
99. Tominaga K, Pereira-Smith OM. The genomic organization, promoter position and expression profile of the mouse MRG15 gene. Gene 2002; 294: 215-224.
100. Tominaga K, Tominaga E, Ausserlechner MJ, Pereira-Smith OM. The cell senescence inducing gene product MORF4 is regulated by degradation via the ubiquitin/proteasome pathway. Exp Cell Res 2010; 316(1): 92-102.
101. Ikura T, Ogryzko VV, Grigoriev M, et al. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell 2000; 102: 463-473.
102. Pardo PS, Leung JK, Lucchesi JC, Pereira-Smith OM. MRG15 a novel chromodomain protein is present in two distinct multiprotein complexes involved in transcriptional activation. J Biol Chem 2002; 277: 50860-50866.
103. Yochum GS, Ayer DE. Role for the mortality factors MORF4, MRGX, and MRG15 in transcriptional repression via associations with Pf1, mSin3A, and Transducin-Like Enhancer of Split. Mol Cell Biol 2002; 22: 7868-7876.
104. Cai Y, Jin J, Tomomori-Sato C, et al. Identification of new subunits of the multiprotein mammalian TRRAP/TIP60-containing histone acetyltransferase complex. J Biol Chem 2003; 278: 42733-42736.
105. Doyon Y, Selleck W, Lane WS, Tan S, Cote J. Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans. Mol Cell Biol 2004; 24: 1884-1896.
106. Doyon Y, Cote J. The highly conserved and multifunctional NuA4 HAT complex. Curr Opin Genet Dev 2004; 14(2): 147-154.
107. Doyon Y, Cayrou C, Ullah M, et al. ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. Mol Cell 2006; 21: 51-64.
108. Hayakawa T, Ohtani Y, Hayakawa N, et al. RBP2 is an MRG15 complex component and down-regulates intragenic histone H3 lysine 4 methylation. Genes Cells 2007; 12: 811-826.
109. Sardiu ME, Cai Y, Jin J, Swanson SK, et al. Probabilistic assembly of human protein interaction networks from label-free quantitative proteomics. Proc Natl Acad Sci USA 2008; 105: 1454-1459.
110. Luco RF, Pan Q, Tominaga K, Blencowe BJ, Pereira-Smith OM, Misteli T. Regulation of alternative splicing by histone modifications. Science 2010; 327(5968): 996-1000.
111. Zhang P, Du J, Sun B, et al. Structure of human MRG15 chromo domain and its binding to Lys36-methylated histone H3. Nucleic Acids Res 2006; 34(22): 6621-6628.
112. Xie L, Pelz C, Wang W, et al. KDM5B regulates embryonic stem cell self-renewal and represses cryptic intragenic transcription. EMBO J 2011; 30(8): 1473-1484.
113. Liao H, Liu XJ, Blank JL, et al. Quantitative proteomic analysis of cellular protein modulation upon inhibition of the NEDD8- activating enzyme by MLN4924. Mol Cell Proteomics 2011; 10(11): M111 009183.
114. Larance M, Kirkwood KJ, Xirodimas DP, Lundberg E, Uhlen M, Lamond AI. Characterization of MRFAP1 Turnover and Interactions Downstream of the NEDD8 Pathway. Mol Cell Proteomics 2012; 11(3): M111 014407.
115. Tominaga K, Kirtane B, Jackson JG, et al. MRG15 regulates embryonic development and cell proliferation. Mol Cell Biol 2005; 25: 2924-2937.
116. Chen M, Takano-Maruyama M, Pereira-Smith OM, Gaufo GO, Tominaga K. MRG15, a component of HAT and HDAC complexes, is essential for proliferation and differentiation of neural precursor cells. J Neurosci Res 2009; 87: 1522-1531.
117. Chen M, Pereira-Smith OM, Tominaga K. Loss of the chromatin regulator MRG15 limits neural stem/progenitor cell proliferation via increased expression of the p21 Cdk inhibitor. Stem Cell Res 2011; 7(1): 75-88.
118. Kusch T, Florens L, MacDonald WH, et al. Acetylation by Tip60 is required for selective histone variant exchange at DNA lesions. Science 2004; 306: 2084-2087.
119. Murr R, Loizou JI, Yang Y-G, et al. Histone acetylation by Trrap-Tip60 modulates loading of repair proteins and repair of DNA double- strand breaks. Nat Cell Biol 2006; 8: 91-99.
120. Garcia SN, Kirtane BM, Podlutsky AJ, Pereira-Smith OM, Tominaga K. Mrg15 null and heterozygous mouse embryonic fibroblasts exhibit DNA-repair defects post exposure to gamma ionizing radiation. FEBS Lett 2007; 581: 5275-5281.
121. Wu J, Chen Y, Lu LY, et al. Chfr and RNF8 synergistically regulate ATM activation. Nat Struct Mol Biol 2011; 18(7): 761-768.
122. Sy SM-H, Huen MS, Chen J. MRG15 is a novel PALB2- interacting factor involved in homologous recombination. J Biol Chem 2009; 284: 21127-21131.
123. Hayakawa T, Zhang F, Hayakawa N, et al. MRG15 binds directly to PALB2 and stimulates homology-directed repair of chromosomal breaks. J Cell Sci 2010; 123: 1124-1130.
124. Martrat G, Maxwell CM, Tominaga E, et al. Exploring the link between MORF4L1 and risk of breast cancer. Breast Cancer Res 2011; 13(2): R40.
125. Pereira-Smith OM, Smith JR. Evidence for the recessive nature of cellular immortality. Science 1983; 221: 964-946.
126. Braig M, Lee S, Loddenkemper C, et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 2005; 436(7051): 660-665.
127. Collado M, Gil J, Efeyan A, Guerra C, et al. Tumour biology: senescence in premalignant tumours. Nature 2005; 436(7051): 642.
128. Michaloglou C, Vredeveld LC, Soengas MS, et al. BRAFE600- associated senescence-like cell cycle arrest of human naevi. Nature 2005; 436(7051): 720-724.
129. Chin L, Pomerantz J, Polsky D, et al. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev 1997; 11(21): 2822-2834.
130. Bardeesy N, Morgan J, Sinha M, et al. Obligate roles for p16(Ink4a) and p19(Arf)-p53 in the suppression of murine pancreatic neoplasia. Mol Cell Biol 2002; 22(2): 635-643.
131. Chen Z, Trotman LC, Shaffer D, et al. Crucial role of p53- dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005; 436(7051): 725-730.
132. Courtois-Cox S, Genther Williams SM, Reczek EE, et al. A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell 2006; 10(6): 459-472.
133. Ventura A, Kirsch DG, McLaughlin ME, et al. Restoration of p53 function leads to tumour regression in vivo. Nature 2007; 445(7128): 661-665.
134. Xue W, Zender L, Miething C, et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007; 445(7128): 656-660.
135. Coppe JP, Patil CK, Rodier F, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008; 6(12): 2853-2868.
136. Kuilman T, Michaloglou C, Vredeveld LC, et al. Oncogeneinduced senescence relayed by an interleukin-dependent inflammatory network. Cell 2008; 133(6): 1019-1031.
137. Kuilman T, Peeper DS. Senescence-messaging secretome: SMSing cellular stress. Nat Rev Cancer 2009; 9(2): 81-94.
138. Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci USA 2001; 98(21): 12072-10277.
139. Liu D, Hornsby PJ. Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. Cancer Res 2007; 67(7): 3117-3126.
140. Bartholomew JN, Volonte D, Galbiati F. Caveolin-1 regulates the antagonistic pleiotropic properties of cellular senescence through a novel Mdm2/p53-mediated pathway. Cancer Res 2009; 69(7): 2878-2886.
141. Chung HY, Cesari M, Anton S, et al. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev 2009; 8(1): 18-30.
142. Laberge RM, Zhou L, Sarantos MR, et al. Glucocorticoids Suppress Selected Components of the Senescence-Associated Secretory Phenotype. Aging Cell 2012; 11(4): 569-578.
143. Takahashi A, Imai Y, Yamakoshi K, et al. DNA damage signaling triggers degradation of histone methyltransferases through APC/C(Cdh1) in senescent cells. Mol Cell 2012; 45(1): 123-131.
144. Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol 2010; 12(7): 676-685.
145. Krizhanovsky V, Yon M, Dickins RA, et al. Senescence of activated stellate cells limits liver fibrosis. Cell 2008; 134(4): 657-667.
146. Baker DJ, Wijshake T, Tchkonia T, et al. Clearance of p16Ink4apositive senescent cells delays ageing-associated disorders. Nature 2011; 479(7372): 232-236.